Related Articles
Viral and host factors associated with outcomes of hepatitis C virus infection (Review)
Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C
MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection
Zinc: A complementary factor in the treatment of chronic hepatitis C? (Review)
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C